Detection Technology celebrates the official opening of its new India site

Detection Technology officially opened a new service and production facility in Greater Delhi to strengthen its presence in India, with the Finnish ambassador attending; the site will produce modular X‑ray detector building blocks under a 'Made in India' label to shorten lead times and lower costs. Shipments are set to begin immediately, with initial operations focused on end‑assembly and final testing of security X‑ray detector boards and a roadmap to scale into TFT flat panel assembly for industrial and medical imaging, plus on‑site product demonstrations. The move, executed through wholly owned DT Detection Technology India Pvt Ltd, positions the company (DETEC, Nasdaq First North Growth Market Finland) to capture demand from Indian infrastructure and inspection markets and to enhance local market access and supply‑chain efficiency.

Analysis

Detection Technology formally opened a fully owned service and production facility in Greater Delhi on 9 December 2025, an event attended by the Finnish Ambassador and company executives that signals a strategic commitment to the Indian market. Management stated shipments of "Made in India" modular X‑ray detector building blocks will begin immediately, with initial operations focused on end‑assembly and final testing of security X‑ray detector boards, and the entity will operate as DT Detection Technology India Private Ltd.

The company outlined a clear roadmap to scale the site to TFT flat panel detector assembly to address industrial and medical imaging demand, and emphasized shorter lead times, lower costs and local product demonstrations as commercial advantages. CEO Hannu Martola and Arve Lukander framed the move as positioning Detection Technology to support India’s infrastructure growth in healthcare, airports, seaports, rail and border inspection, indicating targeted end markets for near‑term sales outreach.

Operational implications include potential supply‑chain resilience, improved customer proximity and faster time to market for Indian customers, which could lift competitiveness and margin profile if scale is achieved. Market signals are mildly positive (sentiment score 0.25) but the business case hinges on execution of the scale‑up to TFT panels and visible shipment/revenue growth metrics, so investors should watch early production throughput, order intake and management updates closely.

Key Decisions for Investors

• Monitor initial shipment volumes, local sales traction and management commentary over the next quarters to validate claims that "Made in India" production shortens lead times and reduces costs
• Favor a wait‑for‑evidence approach: consider holding or modestly increasing exposure only after clear throughput and revenue uplift from the Delhi site appears, given execution risk in scaling to TFT flat panel assembly
• Track order flow from stated end markets (healthcare, airports, seaports, rail and border inspection) and any disclosures on margin impact or local pricing advantages, as these will determine the facility's contribution to company fundamentals
• Watch for operational KPIs such as time‑to‑shipment, quality metrics from final testing and any incremental capital or hiring disclosures that would signal a sustained scale‑up